Good Pharmacovigilance Practice (GVP) is a guide for the implementation of pharmacovigilance in member states, the requirements of which apply to marketing authorization holders and competent authorities in the field of pharmacovigilance.*

*Decision No. 87 of the Council of the Eurasian Economic Commission dated November 3, 2016 “On Approval of the Good Pharmacovigilance Practice Rules of the Eurasian Economic Union” (as amended by Decision No. 81 of the Council of the Eurasian Economic Commission dated May 19, 2022). Effective date — December 6, 2022.